Lincomycin (X-GEN Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Lincomycin drug offered from X-GEN Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: X-GEN Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: lincomycin hydrochloride
SUBSTANCE NAME: LINCOMYCIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-07-05
END MARKETING DATE: 0000-00-00


Lincomycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLincomycin from X-GEN Pharmaceuticals, Inc.
LABELER NAME: X-GEN Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/mL)
START MARKETING DATE: 2015-07-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 39822-0350_5ea7fe16-a790-42aa-ad0f-523a02981f2a
PRODUCT NDC: 39822-0350
APPLICATION NUMBER: ANDA201746

Other LINCOMYCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pharmacia and Upjohn Company LLCLincocin
X-GEN Pharmaceuticals, Inc.Lincomycin